Evidence map›Paper›PMID 23378892›Full record

ArticleChemical science2013

Synthesis and characterization of non-hydrolysable diphosphoinositol polyphosphate second messengers.

Mingxuan Wu, Barbara E Dul, Alexandra J Trevisan, Dorothea Fiedler

Open access · greenAbstract read
In one paragraph

Article in Chemical science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Affinity-Based Interactome Mapping of Inositol Pyrophosphates Reveals 4/6-PP-InsPAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Fluorination Influences the Bioisostery of Myo-Inositol Pyrophosphate Analogs.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The inositol pyrophosphate 5-InsPScience advances · 2020
    Article
  16. The Key Role of IPMolecules (Basel, Switzerland) · 2020
    Review
  17. InsPProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Review
  19. Control of XPR1-dependent cellular phosphate efflux by InsPProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mingxuan WuDepartment of Chemistry, Princeton University, Washington Rd., 85 Princeton, NJ, 08544, USA. Tel: +1 609 258 1025.
Barbara E Dul
Alexandra J Trevisan
Dorothea Fiedler
Princeton University · US

Funding

Elucidating cellular signaling functions of diphosphoinositol polyphosphatesR00GM087306 · NIGMS · PRINCETON UNIVERSITY · PI FIEDLER, DOROTHEA · 2010 to 2012
$740k
NIGMS NIH HHS R00 GM087306
6 · The paper itself

Abstract

The diphosphoinositol polyphosphates (PP-IPs) are a central group of eukaryotic second messengers. They regulate numerous processes, including cellular energy homeostasis and adaptation to environmental stresses. To date, most of the molecular details in PP-IP signalling have remained elusive, due to a lack of appropriate methods and reagents. Here we describe the expedient synthesis of methylene-bisphosphonate PP-IP analogues. Their characterization revealed that the analogues exhibit significant stability and mimic their natural counterparts very well. This was further confirmed in two independent biochemical assays, in which our analogues potently inhibited phosphorylation of the protein kinase Akt and hydrolytic activity of the Ddp1 phosphohydrolase. The non-hydrolysable PP-IPs thus emerge as important tools and hold great promise for a variety of applications.

Identifiers

PMID23378892
PMCPMC3558982
OpenAlexW2157265939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.